|
CRY1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.28170005112105E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79442999999058E-05 |
| Normal-vs-Stage2 |
3.89690000002219E-06 |
| Normal-vs-Stage3 |
7.63879959286839E-10 |
| Normal-vs-Stage4 |
6.11688477647476E-12 |
| Stage1-vs-Stage2 |
2.038400E-01 |
| Stage1-vs-Stage3 |
9.923700E-03 |
| Stage1-vs-Stage4 |
4.217800E-04 |
| Stage2-vs-Stage3 |
5.014600E-01 |
| Stage2-vs-Stage4 |
1.488640E-01 |
| Stage3-vs-Stage4 |
3.649000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.94169996642546E-09 |
| Normal-vs-AfricanAmerican |
4.469900E-02 |
| Normal-vs-Asian |
4.414000E-02 |
| Caucasian-vs-AfricanAmerican |
1.499240E-01 |
| Caucasian-vs-Asian |
7.859400E-01 |
| AfricanAmerican-vs-Asian |
7.142200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.61302091075777E-12 |
| Normal-vs-Female |
5.407000E-04 |
| Male-vs-Female |
1.082910E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.56709999996363E-06 |
| Normal-vs-Age(41-60Yrs) |
5.94109999974002E-07 |
| Normal-vs-Age(61-80Yrs) |
2.19039997251258E-09 |
| Normal-vs-Age(81-100Yrs) |
1.064150E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.567150E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.061800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.671400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.709800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.372400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.191000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.335600E-01 |
| Normal-vs-Grade 2 |
4.20629999999811E-05 |
| Normal-vs-Grade 3 |
3.20889981253458E-10 |
| Normal-vs-Grade 4 |
1.69275704564598E-12 |
| Grade 1-vs-Grade 2 |
2.553200E-01 |
| Grade 1-vs-Grade 3 |
1.635790E-01 |
| Grade 1-vs-Grade 4 |
5.272500E-02 |
| Grade 2-vs-Grade 3 |
8.858900E-03 |
| Grade 2-vs-Grade 4 |
2.33780000002959E-06 |
| Grade 3-vs-Grade 4 |
1.615680E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.603700E-04 |
| Normal-vs-ccB subtype |
6.86195544830071E-12 |
| ccA subtype-vs-ccB subtype |
1.64183999999956E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09169995266001E-09 |
| Normal-vs-N1 |
2.12889999999799E-05 |
| N0-vs-N1 |
2.712600E-01 |
|
|
